Clinical Trials Browser

Not yet recruiting × INDUSTRY × Zoledronic Acid × Clear all

NCT06221072 2024-01-24

A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid

Phase 3 Not yet recruiting

Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors